Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6786-6808
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6786
Table 5 Serum DNA markers for adenoma and colorectal cancer n (%)
MarkerStudySensitivity
Specificity
CRCAdenoma
APC, KRAS, p53Wang et al[185]36 (46)-50 (100)
APC mutationDiehl et al[121]16 (73)1 (9)33 (100)
APC, MLH1, HLTFLeung et al[186]3-28 (6-57)-37-41 (90-100)
Meth SEPT9Lofton-Day et al[134]92 (69)-154 (86)
Grützmann et al[133]73 (58)3 (18)165 (90)
deVos et al[131]62 (69)-132 (89)
Tóth et al[187]88 (96)-78 (85)
TMEF2, NGFR, SEPT9Lofton-Day et al[134]40-69 (30-52)-170 (95)
Meth on 10 genesLee et al[188]210 (87)48 (75)254 (92)
Meth VimentinLi et al[168]48 (59)-102 (93)